PAVmed Inc
NASDAQ:PAVM
PAVmed Inc
NASDAQ:PAVM
Price:
2.19 USD
5.8%
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one
PAVM
stock under the Base Case scenario is
139.87
USD.
Compared to the current market price of 2.19 USD,
PAVmed Inc
is
Undervalued by 98%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PAVM
Relative Value
Base Case
139.87
USD
Undervaluation 98%
Valuation Multiples
Multiples Across Competitors
PAVM Competitors Multiples
PAVmed Inc Competitors
PAVmed Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
PAVmed Inc
NASDAQ:PAVM
|
18.8m USD | 7.7 | -0.3 | -0.6 | -0.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 4.6 | 32.6 | 19.3 | 28.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.1B USD | 18.6 | 69.1 | 56.1 | 70.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126B USD | 5.9 | 37.4 | 24 | 29.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
109.1B USD | 3.4 | 26 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 7.3 | 60.4 | 30.4 | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.8B USD | 3.5 | 56.6 | 18.8 | 39.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.5B EUR | 2.6 | 37.9 | 17.9 | 30.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.8B CNY | 11 | 33.2 | 29 | 29 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.5B USD | 13.5 | 80.6 | 60 | 78.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 8.3 | 36.5 | 26.3 | 28.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
